Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 104, Issue 5, Pages 769-780
Publisher
Springer Nature
Online
2011-02-09
DOI
10.1038/bjc.2011.21
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aurora-C: The youngest of "The Three (Aurora kinase) Tenors" of mitotic symphony
- (2011) Subrata Sen CELL CYCLE
- Aurora kinase B, epigenetic state of centromeric heterochromatin and chiasma resolution in oocytes
- (2010) E Vogt et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer
- (2010) Soley Bayraktar WORLD JOURNAL OF GASTROENTEROLOGY
- AZD1152 Rapidly and Negatively Affects the Growth and Survival of Human Acute Myeloid Leukemia Cells In vitro and In vivo
- (2009) A. Oke et al. CANCER RESEARCH
- The Topoisomerase I Poison CPT-11 Enhances the Effect of the Aurora B Kinase Inhibitor AZD1152 both In vitro and In vivo
- (2009) J. S. Nair et al. CLINICAL CANCER RESEARCH
- Aurora A, centrosome structure, and the centrosome cycle
- (2009) Kara B. Lukasiewicz et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Aurora kinase inhibitors in preclinical and clinical testing
- (2009) Chun Hei Antonio Cheung et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma
- (2009) Arihiro Aihara et al. JOURNAL OF HEPATOLOGY
- Analysis of Aurora B kinase in non-Hodgkin lymphoma
- (2009) Takayuki Ikezoe et al. LABORATORY INVESTIGATION
- Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780
- (2009) Jayasree S. Nair et al. MOLECULAR BIOLOGY OF THE CELL
- Pancreatic cancer: molecular pathogenesis and new therapeutic targets
- (2009) Han H. Wong et al. Nature Reviews Gastroenterology & Hepatology
- Clinical Experience with Aurora Kinase Inhibitors: A Review
- (2009) D. S. Boss et al. ONCOLOGIST
- Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib
- (2008) G Bocci et al. BRITISH JOURNAL OF CANCER
- The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma
- (2008) Robert P. Evans et al. BRITISH JOURNAL OF HAEMATOLOGY
- Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts
- (2008) E. Walsby et al. HAEMATOLOGICA
- Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity
- (2008) J. Cummings et al. MOLECULAR CANCER THERAPEUTICS
- Prolonged Versus Standard Gemcitabine Infusion: Translation of Molecular Pharmacology to New Treatment Strategy
- (2008) S. A. Veltkamp et al. ONCOLOGIST
- Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis
- (2008) Therese Ostberg et al. ARTHRITIS RESEARCH & THERAPY
- Systemic and targeted therapy for advanced colon cancer
- (2008) Sanjay R Hegde et al. Expert Review of Gastroenterology & Hepatology
- Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cells
- (2007) Amalia Azzariti et al. BIOCHEMICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started